Chesapeake Urology

Towson, Maryland 21204

1 studies enrolling now · 7 studies all time

What they study most

Abiraterone Acetate, Adenocarcinoma of the Prostate, Androgens, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Benign Prostatic Hyperplasia, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Cytochrome P-450, Enzyme Inhibitors, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists

Studies at this site

• A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer — Recruiting now
• A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) — Running, not enrolling
• Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer — Completed
• To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer — Stopped early
• ExoDx Prostate Evaluation in Active Surveillance Patient Population — Status unconfirmed
• Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer — Completed
• Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate) — Completed